GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,980 | -1,840 | -5,150 | N/A | N/A |
| Depreciation Amortization | 700 | 360 | 1,220 | N/A | N/A |
| Other Working Capital | -170 | 640 | N/A | N/A | N/A |
| Other Operating Activity | 10 | 10 | -910 | 0 | 0 |
| Operating Cash Flow | $-2,440 | $-830 | $-4,840 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -10 | N/A | N/A | N/A |
| Other Investing Activity | -100 | -70 | -110 | 0 | 0 |
| Investing Cash Flow | $-120 | $-80 | $-110 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,580 | 70 | 5,900 | 0 | 0 |
| Financing Cash Flow | $4,580 | $70 | $5,900 | $N/A | $N/A |
| Exchange Rate Effect | -50 | -30 | -70 | N/A | N/A |
| Beginning Cash Position | 1,290 | 1,290 | 420 | N/A | N/A |
| End Cash Position | 3,260 | 410 | 1,290 | N/A | N/A |
| Net Cash Flow | $1,970 | $-880 | $860 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,440 | -830 | -4,840 | N/A | N/A |
| Free Cash Flow | -2,440 | -830 | -4,840 | 0 | 0 |